Please find attached the Company''s clarification to your emailed letter no. L/SURV/ONL/PV/SJ/202-2026-3364 dated 09/February/2026, in respect of significant movement in the price of the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries has responded to a BSE query dated 9 February 2026 regarding an unusual rise in its share price. The company stated that there is no undisclosed price-sensitive information or any announcement under Regulation 30 of SEBI LODR Regulations that could explain the price movement. It attributed the share price rise entirely to market conditions and market-driven activity. The company also assured the exchange that any future price-sensitive information will be disclosed in a timely manner as required by regulations.
This is a routine clarification with no negative implications. Investors can interpret the response as the company confirming it has no hidden catalysts behind the rally, which means the price movement was speculative or driven by broader market sentiment rather than company-specific fundamentals.